Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The role of the annexin A2 heterotetramer in vascular fibrinolysis.
Blood. 2011 Nov 3;118(18):4789-97. doi: 10.1182/blood-2011-06-334672. Epub 2011 Sep 8.
Blood. 2011.
PMID: 21908427
Free article.
Review.
S100A10 regulates plasminogen-dependent macrophage invasion.
O'Connell PA, Surette AP, Liwski RS, Svenningsson P, Waisman DM.
O'Connell PA, et al. Among authors: surette ap.
Blood. 2010 Aug 19;116(7):1136-46. doi: 10.1182/blood-2010-01-264754. Epub 2010 Apr 27.
Blood. 2010.
PMID: 20424186
Free article.
Item in Clipboard
Regulation of fibrinolysis by S100A10 in vivo.
Surette AP, Madureira PA, Phipps KD, Miller VA, Svenningsson P, Waisman DM.
Surette AP, et al.
Blood. 2011 Sep 15;118(11):3172-81. doi: 10.1182/blood-2011-05-353482. Epub 2011 Jul 18.
Blood. 2011.
PMID: 21768297
Free article.
Item in Clipboard
Plasminogen receptor S100A10 is essential for the migration of tumor-promoting macrophages into tumor sites.
Phipps KD, Surette AP, O'Connell PA, Waisman DM.
Phipps KD, et al. Among authors: surette ap.
Cancer Res. 2011 Nov 1;71(21):6676-83. doi: 10.1158/0008-5472.CAN-11-1748.
Cancer Res. 2011.
PMID: 22042827
Item in Clipboard
The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis.
Madureira PA, O'Connell PA, Surette AP, Miller VA, Waisman DM.
Madureira PA, et al. Among authors: surette ap.
J Biomed Biotechnol. 2012;2012:353687. doi: 10.1155/2012/353687. Epub 2012 Oct 14.
J Biomed Biotechnol. 2012.
PMID: 23118506
Free PMC article.
Review.
Item in Clipboard
ErbB2-driven downregulation of the transcription factor Irf6 in breast epithelial cells is required for their 3D growth.
Khan IA, Yoo BH, McPhee M, Masson O, Surette A, Dakin-Hache K, Younis T, Bethune G, Rosen KV.
Khan IA, et al.
Breast Cancer Res. 2018 Dec 13;20(1):151. doi: 10.1186/s13058-018-1080-1.
Breast Cancer Res. 2018.
PMID: 30545388
Free PMC article.
Item in Clipboard
Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies.
Surette A, Yoo BH, Younis T, Matheson K, Rameh T, Snowdon J, Bethune G, Rosen KV.
Surette A, et al.
Breast Cancer Res Treat. 2021 Jun;187(3):743-758. doi: 10.1007/s10549-021-06164-0. Epub 2021 Mar 16.
Breast Cancer Res Treat. 2021.
PMID: 33728523
Item in Clipboard
Using Deep Learning to Predict Final HER2 Status in Invasive Breast Cancers That are Equivocal (2+) by Immunohistochemistry.
Rasmussen SA, Taylor VJ, Surette AP, Barnes PJ, Bethune GC.
Rasmussen SA, et al. Among authors: surette ap.
Appl Immunohistochem Mol Morphol. 2022 Nov-Dec 01;30(10):668-673. doi: 10.1097/PAI.0000000000001079. Epub 2022 Oct 17.
Appl Immunohistochem Mol Morphol. 2022.
PMID: 36251973
Item in Clipboard
Cite
Cite